ZETA GLOBAL HOLDINGS CORP. (ZETA): what the price assumes

In the published model solve dated 2026-Q2, anchored at $22.07, ZETA GLOBAL HOLDINGS CORP. (ZETA) is priced for today's economics sustained for ~6.9 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-28.

Generated: 2026-08-01 · Exported: 2026-08-03 · Source: https://boothcheck.com/report/ZETA

Headline

FieldValue
TickerZETA
CompanyZETA GLOBAL HOLDINGS CORP.
Current price$22.07/sh
CompositionUS 96% / International 4%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisrevenue-multiple
EV / sales paid3.6x
Steady-state operating margin assumed24.3%
Must persist for6.9y

Solve inputs: computed at a 13.3% cost of capital; growth searched up to the 25% self-funding ceiling; each 1pp moves the implied horizon ~1.7 years.

Reconcile: at the x-ray's 9.3% required return this reads ~7.3%/yr; the models below use their own rates.

How unusual the bet is: elevated

ReferenceValue
vs own history-0.48σ
sustained it ~6.9 years at this level23%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset6.31x2expensive
Earnings2.36x1expensive
Relative0.46x3justifies
Growth0.63x4justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.9%); the inversion above states its own rate.

Per-Model Detail (n=10)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$38.650.57xyesFCF base $0.2B, growth 25% (input: historical growth), terminal g 4.0%, WACC 8.9%, 7yr projection
DCF Exit MultipleGrowth$29.250.75xyesExit EV/EBITDA: 61.5x / 64.5x / 67.5x (bear / base = today's held flat / bull), 7yr
Relative ValuationRelative$48.180.46xyesP/S fallback (negative EPS): Sector P/S 8.0x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$3.695.98xyesBook value floor: BV/sh $3.69, ROE negative
Two-Stage Excess ReturnAsset$3.326.65xyesBook value with convergence: BV/sh $3.69, ROE converges to ke
Discounted Future Market CapGrowth$32.020.69xyesRev $1.4B, growth 30% (input: historical growth; tapered), Terminal P/S: 2.9x / 3.7x / 4.4x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth$54.650.40xyesMargin ramp: -2% → 22% over 7yr, rev growth 30% (input: historical growth; tapered)
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelative$8.732.53xyesEBITDA $0.08B × sector EV/EBITDA 25.0x
FCF YieldEarnings$9.352.36xyesFCF $199.7M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$0.7927.93xyesSBC-adj FCF $0.01B (FCF $0.20B − SBC $0.19B) capitalized at Kₑ (excluded from median)
Ben Graham FormulaEarningsno
ROIC-Justified P/BAssetno
P/Sales SectorRelative$48.180.46xyesRevenue $1.44B × sector P/S 8.0x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$91.5m
Net debt / NOPAT (after-tax)-43.77x (net cash)
Net debt / operating income (pre-tax)-34.58x (net cash)
Interest coverage3.3x
Share count CAGR (dilution)15.5%
Burning cashno

Bullet Takeaways

Bull Case

Marketing technology is a sector where the winner is whoever has the best data and can act on it fastest, and that is the lens through which Zeta's case is strongest. The platform combines a proprietary data set with AI to help brands target and message customers, and the company describes its edge as building "new products on a timely and cost-effective basis, meeting evolving customer needs, providing best-in-class data security, extending our core technology into new applications." In martech, scale begets scale: more customers and more data improve the models, which improves the targeting, which attracts more customers. Zeta is demonstrating that flywheel through its existing base rather than just new logos, with scaled-customer average revenue per user up 13% to about $2.1 million in 2025 and super-scaled accounts reaching about $6.16 million. Land-and-expand at that pace is the healthiest growth a software company can have, because it monetizes relationships it already paid to win.

The top-line momentum is genuinely strong. Full-year 2025 revenue grew 30% to $1.305 billion, the fourth quarter rose 25% to $395 million, and the company has now strung together eighteen consecutive beat-and-raise quarters. A consistent beat-and-raise record signals management is forecasting conservatively and executing ahead of its own guidance, which is the opposite of the over-promising that sinks many growth-software stories. The Marigold acquisition adds enterprise relationships and cross-sell, and 2026 guidance for 34% to 35% revenue growth reflects both the acquisition and continued organic strength in the low-twenties.

The inflection toward GAAP profitability is the part the market is starting to credit. Zeta posted positive GAAP net income of $6.5 million in the fourth quarter, a 1.7% margin, and guided to positive GAAP net income for full-year 2026. For a growth-software company, crossing into GAAP profitability while still growing north of 30% is the signal that the unit economics work and the model can self-fund. The valuation lenses reflect a name in transition: the relative-multiple and growth-DCF methods support the price, and analysts carry a strong-buy consensus with targets well above the current level.

Bear Case

The cleanest bear observation is that Zeta's reported profitability and its actual profitability are different numbers, and the gap is paid by shareholders. The company reported positive GAAP net income in the fourth quarter, but the full-year 2025 GAAP result was a net loss of $31.5 million, which included about $178 million of stock-based compensation. Stock-based compensation is a real cost, it is the equity handed to employees instead of cash, and at $178 million against a business this size it is the difference between the GAAP loss and the adjusted profit the company prefers to highlight. The consequence shows up directly in the share count, which is growing at roughly 15% a year. A company diluting holders at that pace has to grow per-share value much faster than total value just to stand still, and the buyer is funding the growth partly through their own dilution.

The growth itself deserves a second look. Headline 2026 guidance is for 34% to 35% revenue growth, but excluding political-candidate revenue and the Marigold acquisition, the underlying organic rate is 20% to 21%. Political revenue is episodic, tied to election cycles, and acquisition revenue is bought, not earned, so the durable organic engine is meaningfully slower than the headline suggests. For a stock whose price embeds years of high growth, the distinction between 35% reported and 20% organic is the whole valuation question, because the organic rate is what compounds after the election fades and the acquisition laps.

The structural risk is regulatory, and it sits at the heart of the business model. Zeta's value depends on collecting and acting on consumer data, and the 10-K is candid that regulation governs "the ways in which we may use or disclose data," that frameworks like "the GDPR permit data protection authorities to impose penalties for violations," and that the company expects "existing legal complexity and uncertainty regarding international data transfers to continue." Tightening privacy law, restrictions on data transfers, or the broader deprecation of tracking identifiers could erode the proprietary data advantage the entire thesis rests on. The valuation amplifies the stakes: at about 3.4 times revenue the price implies the business eventually earns a roughly 24% operating margin and grows at its self-funding ceiling for about six years, a path only about 28% of comparable fast-growers have sustained, and the asset and earnings-power lenses already call the price expensive. If the organic growth normalizes or a privacy shock hits, there is little static value beneath the price to catch it.

Valuation

Trailing operating profit sits below the steady-state level the price assumes, so the stock is best read against its sales rather than its earnings. At about 3.4 times revenue, the price implies the business eventually earns an operating margin near 24% and grows revenue at its self-funding ceiling for roughly six years. That is a demanding combination: the company must both scale its margin from today's near-breakeven GAAP level and sustain rapid growth, and only about 28% of comparable fast-growers have held this pace for six years. The read is labeled elevated, above what the fundamentals comfortably support.

The valuation families split as they do for a high-growth, not-yet-GAAP-profitable software name. The relative-multiple and growth-DCF lenses support the price, while the asset-based and earnings-power lenses call it expensive. The reconciliation is the margin-expansion story: the static methods value the thin current earnings, while the forward lenses credit the operating leverage the platform should produce as it scales. The price is paying for that leverage to materialize, which means the durability of the organic growth and the path to real GAAP margins, not just adjusted ones, are what the valuation rests on.

Solvency is adequate but not a fortress. The company holds modest net cash, about $91 million, against roughly $197 million of gross debt, and interest coverage is thin given the near-breakeven operating income. The more important balance-sheet fact is the equity dilution, not the debt: stock-based compensation around $178 million a year and a 15% annual increase in shares mean the per-share trajectory lags the total-business trajectory. The downside is not insolvency; it is a re-rating if organic growth slows toward the low twenties, if the margin expansion proves slower than the price assumes, or if data regulation pressures the model, against a price that only the growth-crediting lenses currently justify.

Catalysts

The fourth-quarter and full-year 2025 results, reported in early 2026, extended a long run of outperformance. Fourth-quarter revenue rose 25% to $395 million, full-year revenue grew 30% to $1.305 billion, and the company logged its eighteenth consecutive beat-and-raise quarter, while posting positive GAAP net income of $6.5 million in the quarter against a full-year GAAP net loss of $31.5 million driven by stock-based compensation. The scaled-customer monetization continued, with average revenue per user climbing on both scaled and super-scaled accounts.

The 2026 guidance and the Marigold acquisition are the forward catalysts. Management raised full-year 2026 revenue guidance to $1.749 to $1.762 billion, 34% to 35% growth, with organic growth excluding political and Marigold at 20% to 21%, and guided to adjusted EBITDA margins above 22% and positive full-year GAAP net income. The integration of Marigold and the cross-sell into its enterprise base is the lever to watch for whether the acquisition adds durable growth or just one-time scale.

Sentiment is strongly positive. Analysts carry a strong-buy consensus with an average price target around $28, and Bank of America raised its target to $28 with a buy rating. The events most likely to move the thesis from here are the organic-growth prints once political revenue fades, the pace of GAAP margin improvement against the heavy stock-based compensation, the integration of Marigold, and any change in the data-privacy regulatory landscape that bears on the platform's data advantage.

Peer Cohorts (Per Segment, With Filing Citations)

Zeta Global (consolidated) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Zeta Global Q4 2025 results and 2026 guidance · Zeta Global FY2025 10-K · Zeta Global Q4 2025 results, February 2026 · Zeta Global Q4 2025 results and guidance · analyst notes via stockanalysis.com and BofA, 2026 · Zeta Global Q4 2025 results · Zeta Global 2026 guidance

View the full interactive ZETA report on boothcheck